EML1 Antikörper (C-Term)
Kurzübersicht für EML1 Antikörper (C-Term) (ABIN632123)
Target
Alle EML1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- EML1 antibody was raised against the C terminal of EML1
-
Aufreinigung
- Affinity purified
-
Immunogen
- EML1 antibody was raised using the C terminal of EML1 corresponding to a region with amino acids YPCSQFRAPSHIYGGHSSHVTNVDFLCEDSHLISTGGKDTSIMQWRVI
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
EML1 Blocking Peptide, (ABIN936166), is also available for use as a blocking control in assays to test for specificity of this EML1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EML1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EML1 (Echinoderm Microtubule Associated Protein Like 1 (EML1))
-
Andere Bezeichnung
- EML1
-
Hintergrund
- Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type.
-
Molekulargewicht
- 92 kDa (MW of target protein)
Target
-